抗甲状腺药物对格雷夫斯病和毒性结节性甲状腺肿放射性碘治疗结果的影响。 - Suppr

Suppr

超能文献

Influence of antithyroid drugs on the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre.

作者信息

Sabri O, Zimny M, Buell U

出版信息

Eur J Nucl Med Mol Imaging. 2002 Jan;29(1):160-1. doi: 10.1007/s00259-001-0673-5. Epub 2001 Nov 9.

DOI:10.1007/s00259-001-0673-5

PMID:11807618

Abstract

摘要

相似文献

Influence of antithyroid drugs on the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre.

Eur J Nucl Med Mol Imaging. 2002 Jan;29(1):160-1. doi: 10.1007/s00259-001-0673-5. Epub 2001 Nov 9.

Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre?

Eur J Nucl Med. 2001 Sep;28(9):1360-4. doi: 10.1007/s002590100565.

Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements.

J Nucl Med. 1996 Feb;37(2):228-32.

Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.

Eur J Clin Invest. 2009 Jan;39(1):51-7. doi: 10.1111/j.1365-2362.2008.02061.x.

Hyperthyroidism.

Lancet. 2003 Nov 8;362(9395):1584-5. doi: 10.1016/S0140-6736(03)14759-9.

A randomized trial evaluating a block-replacement regimen during radioiodine therapy.

Eur J Clin Invest. 2011 Jul;41(7):693-702. doi: 10.1111/j.1365-2362.2010.02452.x. Epub 2010 Dec 22.

[Basedown disease, thyroid gland autonomy, nodular goiter. When is radiotherapy indicated?].

MMW Fortschr Med. 2003 Apr 24;145(17):47-9.

Outcome of 131I therapy in hyperthyroidism using a 550MBq fixed dose regimen.

Ulster Med J. 2013 May;82(2):85-8.

Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.

QJM. 1995 Mar;88(3):175-80.

Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial.

Eur J Endocrinol. 2003 Dec;149(6):485-92. doi: 10.1530/eje.0.1490485.

本文引用的文献

Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre?

Eur J Nucl Med. 2001 Sep;28(9):1360-4. doi: 10.1007/s002590100565.

[Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents].

Nuklearmedizin. 2001 Aug;40(4):111-5.

[Characterization of therapy failures in radioiodine therapy of Graves' disease without simultaneous antithyroid agents].

Nuklearmedizin. 2001 Feb;40(1):1-6.

[Reduced antithyroid agents as a result of radioiodine therapy?].

Nuklearmedizin. 2000;39(2):N25-6.

Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.

Thyroid. 1999 Dec;9(12):1181-8. doi: 10.1089/thy.1999.9.1181.

Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication.

J Clin Endocrinol Metab. 1999 Apr;84(4):1229-33. doi: 10.1210/jcem.84.4.5588.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Influence of antithyroid drugs on the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre.

作者信息

Sabri O, Zimny M, Buell U

出版信息

Eur J Nucl Med Mol Imaging. 2002 Jan;29(1):160-1. doi: 10.1007/s00259-001-0673-5. Epub 2001 Nov 9.

DOI:10.1007/s00259-001-0673-5

PMID:11807618

Abstract

摘要